Such considerations seem justified, as an effective inhibition of KCa3.1 by genetic and pharmacological means markedly reduces the proliferation of tumor cells and it may also alter the susceptibility of the tumor towards established cancer therapies. The gene discussed is KCNN4; the disease is neoplasm.